Dean Petkanas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Neuropathix, Inc Highlights Revenue Related to its Grant Award with NIH-NINDS

The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing funding specifically in the Development of KLS-13019 for Neuropathic

United statesKostenloser wertpapierhandelKathryn brownLouie tomaNeuropathix incPennsylvania biotechnology centerNational institutes of healthDrug administrationCompany twitterInitiative helping end addictionSecurities exchangeNational instituteHelping end addiction long termDean petkanasNational institutesBucks county

Neuropathix, Inc Highlights Revenue Related to its Grant Award with NIH-NINDS

Neuropathix, Inc Highlights Revenue Related to its Grant Award with NIH-NINDS
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesKathryn brownLouie tomaNeuropathix incPennsylvania biotechnology centerNational institutes of healthDrug administrationCompany twitterInitiative helping end addictionSecurities exchangeNational instituteHelping end addiction long termDean petkanasNational institutesBucks countySecurities act

Neuropathix, Inc Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

Neuropathix, Inc Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKathryn brownLouie tomaNeuropathix incSubstance abuse researchPennsylvania biotechnology centerNational institute of healthNational institutes of healthDrug administrationCompany twitterSecurities exchangeNational institute of neurological disordersNational institutePublished preclinical data showsEffective than cannabidiol

Neuropathix, Inc Welcomes Daniele Piomelli, PhD, MD to the Company s Scientific Advisory Board

Neuropathix, Inc Welcomes Daniele Piomelli, PhD, MD to the Company s Scientific Advisory Board
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesLouise turner arnoldDaniele piomelliLouie tomaNeuropathix incPennsylvania biotechnology centerDrug administrationCompany twitterCompany scientific advisory boardItalian institute of technologyCannabinoid researchSecurities exchangeChemistry at university of californiaScientific advisoryNature medicineNature neuroscience

Neuropathix, Inc Welcomes Daniele Piomelli, PhD, MD to the Company s Scientific Advisory Board

Neuropathix, Inc Welcomes Daniele Piomelli, PhD, MD to the Company s Scientific Advisory Board
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.